Cogent Biosciences: Peers

The FY2025 (Dec) proxy of Cogent Biosciences names 20 peer companies for pay. Among Cogent Biosciences and these peers, CEO pay was the highest of 7 and total shareholder return was the highest of 7.

1st highest of 7in Cogent Biosciences and its pay peers, FY2025 (Dec) by CEO pay:

$4.6M$27.8M

1st highest of 7in Cogent Biosciences and its pay peers, FY2025 (Dec) by total shareholder return:

$20$414

Pay peer group, FY2025 (Dec) proxy

Arcus Biosciences
Immunome
Anaptysbio
Celldex Therapeutics
Kura Oncology
Relay Therapeutics
Allogene Therapeutics, Inc.Not disclosedNot disclosed
Arvinas, Inc.Not disclosedNot disclosed
Bicycle Therapeutics plcNot disclosedNot disclosed
Blueprint Medicines CorporationNot disclosedNot disclosed
Day One Biopharmaceuticals, Inc.Not disclosedNot disclosed
Erasca, Inc.Not disclosedNot disclosed
IGM Biosciences, Inc.Not disclosedNot disclosed
Iovance BiotherapeuticsNot disclosedNot disclosed
Kiniksa Pharmaceuticals, Ltd.Not disclosedNot disclosed
Nuvalent, Inc.Not disclosedNot disclosed
SpringWorks Therapeutics, Inc.Not disclosedNot disclosed
Syndax PharmaceuticalsNot disclosedNot disclosed
Tyra Biosciences, Inc.Not disclosedNot disclosed
XencorNot disclosedNot disclosed
20 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.